These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7934489)

  • 1. Donor leucocyte infusions for relapse in chronic myelogenous leukaemia.
    Kumar L
    Lancet; 1994 Oct; 344(8930):1101-2. PubMed ID: 7934489
    [No Abstract]   [Full Text] [Related]  

  • 2. [Successful treatment with donor leukocyte transfusion followed by interferon-alpha in a patient with relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation].
    Maeda A; Yamamoto K; Kotone Y; Yamashita K; Yoshinaga N; Hirata H; Asagoe K; Nohgawa M; Takahashi A; Ohno H; Tashima M; Sasada M
    Rinsho Ketsueki; 1998 Jun; 39(6):442-6. PubMed ID: 9695673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular remission induced by fractionated dose-escalating donor leukocyte infusion without graft-versus-host disease in a patient with chronic myelogenous leukemia relapsed after allogeneic bone marrow transplantation.
    Inai K; Wano Y; Yamamoto S; Ikebata Y; Iwasaki H; Tsutani H; Naiki H; Ueda T
    Anticancer Res; 1999; 19(6C):5631-4. PubMed ID: 10697631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Leukocyte transfusion as therapy of recurrent CML after allogenic bone marrow transplantation].
    Wiesneth M; Hertenstein B; Bunjes D; Novotny J; Stefanic M; Heinze B; Schreiner T; Kubanek B; Heimpel H; Arnold R
    Beitr Infusionsther Transfusionsmed; 1994; 32():276-80. PubMed ID: 9480108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term remission of chronic myelogenous leukaemia following allogeneic transplantation of peripheral blood progenitor cells in the fourth chronic phase after failing previous bone marrow transplantation and donor leukocyte transfusion.
    Stockschläder M; Hassan HT; Löliger C; Zander AR
    Acta Haematol; 1996; 96(4):262-3. PubMed ID: 8922498
    [No Abstract]   [Full Text] [Related]  

  • 6. Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation.
    Bär BM; Schattenberg A; Mensink EJ; Geurts Van Kessel A; Smetsers TF; Knops GH; Linders EH; De Witte T
    J Clin Oncol; 1993 Mar; 11(3):513-9. PubMed ID: 8445426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Elmaagacli AH; Beelen DW; Schaefer UW
    Bone Marrow Transplant; 1997 Dec; 20(12):1045-55. PubMed ID: 9466277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of molecular remission by donor peripheral blood leukocyte therapy in patients relapsing with extramedullary blastic phase chronic myeloid leukemia after allogeneic bone marrow transplantation.
    Bashey A; Shepherd S; Frankel W; Wang-Rodriguez J; Cahill T; Chamberlain M; Mason JR; Ho AD; Corringham RE
    Oncol Rep; 1998; 5(1):281-5. PubMed ID: 9458334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Donor leukocyte transfusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation].
    Itoh T; Hatta Y; Miyajima T; Simojima H; Sawada U; Horie T
    Rinsho Ketsueki; 1998 Jun; 39(6):409-15. PubMed ID: 9695667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reinduction of remission of chronic myeloid leukemia by donor leukocyte transfusion following relapse after bone marrow transplantation: recovery complicated by initial pancytopenia and late dermatomyositis.
    Leber B; Walker IR; Rodriguez A; McBride JA; Carter R; Brain MC
    Bone Marrow Transplant; 1993 Oct; 12(4):405-7. PubMed ID: 8275041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation.
    Raanani P; Dazzi F; Sohal J; Szydlo RM; van Rhee F; Reiter A; Lin F; Goldman JM; Cross NC
    Br J Haematol; 1997 Dec; 99(4):945-50. PubMed ID: 9432048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft vs. leukaemia reactions in chronic myeloid leukaemia.
    Cullis JO; Barrett AJ; Goldman JM
    Eur J Cancer; 1992; 28A(12):2069-74. PubMed ID: 1419304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor leukocyte infusions for chronic myeloid leukemia in relapse after allogeneic bone marrow transplantation.
    Cullis JO; Jiang YZ; Schwarer AP; Hughes TP; Barrett AJ; Goldman JM
    Blood; 1992 Mar; 79(5):1379-81. PubMed ID: 1536963
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon alpha induced and maintained complete remission in chronic granulocytic leukemia in relapse after bone marrow transplantation.
    Borgies P; Ferrant A; Delannoy A; Van den Berghe H; Michaux JL
    Bone Marrow Transplant; 1989 Jan; 4(1):127-8. PubMed ID: 2647178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular remission occurring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Drobyski WR; Roth MS; Thibodeau SN; Gottschall JL
    Bone Marrow Transplant; 1992 Sep; 10(3):301-4. PubMed ID: 1422483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achievement of complete cytogenetic remission after two very low-dose donor leucocyte infusions in a patient with extensive cGVHD relapsing in accelerated phase post allogeneic BMT for CML.
    Rahman SL; Mahendra P; Nacheva E; Sinclair P; Arno J; Marcus RE
    Bone Marrow Transplant; 1998 May; 21(9):955-6. PubMed ID: 9613792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alfa-2a interferon induces molecular remission in post-BMT relapse of chronic myelogenous leukaemia. Report of a case with loss of bcr-abl RNA].
    Casado LF; Steegmann JL; Picó M; Requena MJ; Gómez C; Fernández-Rañada JM
    Sangre (Barc); 1995 Oct; 40(5):417-20. PubMed ID: 8553177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Who may benefit from donor leucocyte infusions after allogeneic stem cell transplantation?
    MacKinnon S
    Br J Haematol; 2000 Jul; 110(1):12-7. PubMed ID: 10930975
    [No Abstract]   [Full Text] [Related]  

  • 19. [Successful treatment of recurrent chronic myelogenous leukemia in allogeneic marrow transplant recipient with the donor leukocyte transfusion, without induction of acute graft-versus-host disease].
    Yamazaki H; Nakao S; Takamatsu H; Ito T; Ueda M; Shiobara S; Matsuda T
    Rinsho Ketsueki; 1995 Jul; 36(7):677-81. PubMed ID: 7563596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia.
    Porter DL; Roth MS; McGarigle C; Ferrara JL; Antin JH
    N Engl J Med; 1994 Jan; 330(2):100-6. PubMed ID: 8259165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.